Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spots
- 9 June 2020
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (10), 1606-1612
- https://doi.org/10.1038/s41436-020-0846-x
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomesMolecular Genetics and Metabolism, 2015
- Reference ranges of serum bile acids in children and adolescentscclm, 2015
- Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophyMolecular Genetics and Metabolism, 2015
- A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newbornsJournal of Lipid Research, 2014
- Neurological Outcome in Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic AcidClinical Neuropharmacology, 2013
- Chronic Diarrhea and Juvenile Cataracts: Think Cerebrotendinous Xanthomatosis and TreatPEDIATRICS, 2009
- Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapyJournal of Inherited Metabolic Disease, 2008
- Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosisBrain, 2000
- A Method for the Quantitation of Conjugated Bile Acids in Dried Blood Spots Using Electrospray Ionization-Mass SpectrometryPediatric Research, 1998
- Diagnosis of Zellweger syndrome by analysis of bile acids and plasmalogens in stored dried blood collected at neonatal screeningThe Journal of Pediatrics, 1987